Drugs / TUM012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05246618 | Mar 2022 → Jul 2023 | ischemic disease | iCoat Medical AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TUM012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05246618 ↗ |
| Route | Other | “Ex-vivo infusion” NCT05246618 ↗ |